Chemeleon Diagnostic Platform

About Chemeleon

Chemeleon's mission is to create simple, accessible, and affordable diagnostic solutions using its proprietary chemical sensor platform. The company's technology enables the detection of a broad range of analytes—including drugs, proteins, and viruses—in a sample-to-answer format visible to the naked eye, requiring no instruments or specialized training. A key strategic achievement is its clinical collaboration with Mayo Clinic to advance its instrument-free cardiac troponin assay for AMI detection. Chemeleon is positioned to transform point-of-care and point-of-need testing by empowering clinicians and consumers with rapid, decentralized diagnostics.

Therapeutic Areas